Brooks Laboratories Limited (BROOKS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Brooks Laboratories Limited (BROOKS) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.19 Million ≈ $34.55K USD) by net assets (Rs1.16 Billion ≈ $12.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Brooks Laboratories Limited (BROOKS) defensive interval to measure how many days the company can operate on defensive assets alone.

Brooks Laboratories Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Brooks Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Brooks Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brooks Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TPC Plus Bhd KLSE:7176	0.228x
B3 Consulting Group AB ST:B3	0.076x
MDI Energia S.A. WAR:MDI	1.692x
Matching Maximize Solution Public Company Limited BK:MATCH	0.012x
PJX Resources Inc V:PJX	-0.754x
Elevation Oncology Inc NASDAQ:ELEV	-0.272x
Solarmax Technology Inc. Common Stock NASDAQ:SMXT	367.037x
Shanyuan Co Ltd TWO:4416	-0.097x

Annual Cash Flow Conversion Efficiency for Brooks Laboratories Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Brooks Laboratories Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see BROOKS company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs981.04 Million ≈ $10.61 Million	Rs17.62 Million ≈ $190.59K	0.018x	+112.17%
2024-03-31	Rs655.85 Million ≈ $7.09 Million	Rs-96.81 Million ≈ $-1.05 Million	-0.148x	+24.67%
2023-03-31	Rs739.53 Million ≈ $8.00 Million	Rs-144.91 Million ≈ $-1.57 Million	-0.196x	+29.70%
2022-03-31	Rs1.34 Billion ≈ $14.53 Million	Rs-374.41 Million ≈ $-4.05 Million	-0.279x	-594.81%
2021-03-31	Rs791.48 Million ≈ $8.56 Million	Rs44.59 Million ≈ $482.19K	0.056x	+159.05%
2020-03-31	Rs984.16 Million ≈ $10.64 Million	Rs-93.89 Million ≈ $-1.02 Million	-0.095x	-98.66%
2019-03-31	Rs1.05 Billion ≈ $11.37 Million	Rs-50.49 Million ≈ $-546.08K	-0.048x	+11.07%
2018-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs-61.81 Million ≈ $-668.48K	-0.054x	-169.74%
2017-03-31	Rs1.24 Billion ≈ $13.41 Million	Rs96.01 Million ≈ $1.04 Million	0.077x	+16.39%
2016-03-31	Rs1.22 Billion ≈ $13.20 Million	Rs81.19 Million ≈ $878.02K	0.067x	+248.09%
2015-03-31	Rs1.11 Billion ≈ $12.05 Million	Rs21.29 Million ≈ $230.26K	0.019x	-81.66%
2014-03-31	Rs1.12 Billion ≈ $12.14 Million	Rs116.98 Million ≈ $1.27 Million	0.104x	+103.74%
2013-03-31	Rs1.05 Billion ≈ $11.40 Million	Rs53.90 Million ≈ $582.89K	0.051x	+361.70%
2012-03-31	Rs912.63 Million ≈ $9.87 Million	Rs-17.83 Million ≈ $-192.84K	-0.020x	-109.59%
2011-03-31	Rs194.27 Million ≈ $2.10 Million	Rs39.59 Million ≈ $428.16K	0.204x	-51.15%
2010-03-31	Rs136.42 Million ≈ $1.48 Million	Rs56.91 Million ≈ $615.45K	0.417x	+144.20%
2009-03-31	Rs85.37 Million ≈ $923.22K	Rs14.58 Million ≈ $157.71K	0.171x	-58.33%
2008-03-31	Rs49.11 Million ≈ $531.11K	Rs20.13 Million ≈ $217.73K	0.410x	+565.61%
2007-03-31	Rs17.58 Million ≈ $190.16K	Rs1.08 Million ≈ $11.71K	0.062x	--

About Brooks Laboratories Limited

NSE:BROOKS India Drug Manufacturers - Specialty & Generic

Market Cap

$21.66 Million

Rs2.00 Billion INR

Market Cap Rank

#24872 Global

#1381 in India

Share Price

Rs68.00

Change (1 day)

+1.54%

52-Week Range

Rs37.11 - Rs161.50

All Time High

Rs194.97